FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. QCOM
6. AZN
7. ORCL
8. AAPL
9. NVS
10. ROIV

Go back to FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia
Regeneron (NASDAQ: REGN) Delayed: 810.31 --0 (-0%)
Previous Close $810.31    52 Week High $592.36 
Open $810.31    52 Week Low $325.35 
Day High $810.31    P/E 212.68 
Day Low $810.31    EPS $3.81 
Volume 48       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.86 --0 (-0%)
Previous Close $14.86    52 Week High $5.58 
Open $14.86    52 Week Low $3.60 
Day High $14.86    P/E N/A 
Day Low $14.86    EPS $0.00 
Volume 4,049       

SANOFI (NASDAQ: SNY) Delayed: 43.16 +0.01 (0.02%)
Previous Close $43.15    52 Week High $44.76 
Open $43.16    52 Week Low $36.81 
Day High $43.16    P/E N/A 
Day Low $43.16    EPS $0.00 
Volume 12,682